Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Biotech
  • General
  • News

Profound Medical Says Growing Body Of Clinical Evidence Points To The Potential Of TULSA Procedure Becoming A Mainstream Treatment Modality Across The Entire Prostate Disease Spectrum

By Benzinga Newsdesk
May 6, 4:45 PM
— So far this year alone, 25 TULSA-related scientific research presentations have been delivered at major medical meetings around the world — — Of those, eight (8) presentations were from leading urologists at AUA

PROF

Read More
2 minute read
  • Earnings
  • Guidance
  • News

Profound Medical Announces Preliminary Unaudited Q4 And FY23 Revenues; Sees Q4 Revenue $1.9M-$2M Vs $2.02M Est.; FY23 Revenue $7.1M-$7.2M Vs $7.22M Est.

By Benzinga Newsdesk
January 3, 5:20 PM
Profound Medical Corp. (NASDAQ:PROF, TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue,

PROF

Read More
1 minute read
  • Earnings
  • Markets
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Trading Ideas

Chord Energy, Profound Medical And 3 Stocks To Watch Heading Into Thursday

By Avi Kapoor
December 28, 5:24 AM
With U.S. stock futures trading slightly higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows:

BLIN

Read More
29 minute read
  • Earnings

Earnings Scheduled For November 2, 2023

By Benzinga Insights
November 2, 4:56 AM
Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.

AAPL

Read More
1 minute read
  • Earnings
  • Markets
  • News
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

TD SYNNEX, Profound Medical And 3 Stocks To Watch Heading Into Tuesday

By Lisa Levin
September 26, 4:18 AM
With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

COST

Read More
22 minute read
  • Earnings

Earnings Scheduled For August 9, 2023

By Benzinga Insights
August 9, 4:54 AM
Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earnings at $0.96 per share on revenue of $18.11 billion.

AADI

Read More
9 minute read
  • Analyst Ratings
  • Downgrades
  • Initiation
  • Intraday Update
  • Upgrades

Benzinga’s Top Ratings Upgrades, Downgrades For August 4, 2023

By Benzinga Insights
August 4, 11:01 AM
Upgrades Citigroup upgraded the previous rating for Telephone and Data Systems Inc (NYSE:TDS) from Neutral to Buy. In…

AAOI

Read More
1 minute read
  • Earnings

Profound Medical: Q1 Earnings Insights

By Benzinga Insights
May 10, 5:15 PM
Profound Medical (NASDAQ:PROF) reported its Q1 earnings results on Wednesday, May 10, 2023 at 04:05 PM. Here’s what…

PROF

Read More
19 minute read
  • Earnings

Earnings Scheduled For May 10, 2023

By Benzinga Insights
May 10, 9:12 AM
Companies Reporting Before The Bell • Nomad Foods (NYSE:NOMD) is projected to report quarterly earnings at $0.42 per share on revenue of $851.81 million.

AADI

Read More
1 minute read
  • Analyst Ratings
  • News
  • Upgrades

Raymond James Upgrades Profound Medical to Strong Buy

By Benzinga Newsdesk
November 4, 2:55 PM
Raymond James analyst Rahul Sarugaser upgrades Profound Medical (NASDAQ:PROF) from Outperform to Strong Buy.

PROF

Posts pagination

1 2 3 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service